Stay updated on Relatlimab + Nivolumab Bioavailability Clinical Trial

Sign up to get notified when there's something new on the Relatlimab + Nivolumab Bioavailability Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab + Nivolumab Bioavailability Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now presents the record for a completed Phase 1 study of relatlimab with nivolumab, including its eligibility criteria, study design, locations, and outcome measures.
    Difference
    44%
    Check dated 2026-11-08T04:24:17.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T01:20:20.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A notice appears above the page announcing NIH website transition updates and explaining that “Super Intelligence” may be used in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T01:16:20.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer revision identifier advances from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T01:03:00.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-11T01:40:47.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, blocking access to the NCT04112498 record and its details on ClinicalTrials.gov.
    Difference
    17%
    Check dated 2026-09-20T00:23:28.000Z thumbnail image

Stay in the know with updates to Relatlimab + Nivolumab Bioavailability Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab + Nivolumab Bioavailability Clinical Trial page.